01 4Duvroq
Main Therapeutic Indication : Hematology
Currency : USD
2020 Revenue in Millions : 6
2019 Revenue in Millions : 0
Growth (%) : New Launch
Main Therapeutic Indication : Hematology
Currency : USD
2021 Revenue in Millions : 22
2020 Revenue in Millions : 6
Growth (%) : 333
Main Therapeutic Indication : Hematology
Currency : USD
2022 Revenue in Millions : 50
2021 Revenue in Millions : 22
Growth (%) : 127
Main Therapeutic Indication : Hematology
Currency : USD
2023 Revenue in Millions : 67
2022 Revenue in Millions : 50
Growth (%) : 50
